T. Feys MBA, MSc

State of the Art II: Immunothrombosis

The second state of the art session of the 2020 annual BSTH meeting focused on Immunothrombosis. First of all, Prof Adam Cunningham (University of Birmingham, UK) addressed the association between Salmonella infection and thrombosis, after which Assistant Prof. Kimberly Martinod (Catholic University Leuven, Belgium) discussed the role of neutrophil extracellular traps at the interface of thrombosis and inflammation. In a third and final lecture of the session, Dr. Frantzeska Frantzeskaki (Attikon University Hospital, NK University of Athens, Greece) turned the attention to immunothrombosis in patients with acute respiratory distress syndrome.

Highlights in multiple myeloma

SUMMARY

Multiple myeloma (MM) remains a devastating disease, even in the era of novel agents. As such, the search for new treatment modalities in both the induction and maintenance setting, to manage newly diagnosed MM ever continues. In recent years, the treatment landscape of patients with relapsed refractory multiple myeloma (RRMM) has also changed dramatically following a long list of positive phase III trials. This overview will give an update of pivotal trials in this setting (IKEMA, OPTIMISMM, CANDOR, BELLINI) as well as discusses some new emerging therapies in the field, including CAR T cell therapy, a B-cell maturation antigen T-cell engager and a novel cereblon E3 ligase modulator (CELMoD) agent.

(BELG J HEMATOL 2020;11(5):203-8)

Journal Scan

SUMMARY

In this section of the BJH, we aim to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on haematology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjh.be) and we will make sure to include it in the journal scan section of the next BJH issue.

(BELG J HEMATOL 2020;11(4):190–3)

The 35^th general annual meeting of the Belgian Hematology Society

SUMMARY

On the 14^th and 15^th of February 2020, the Belgian Hematology Society hosted their 35^th annual meeting in La Hulpe, Brussels. This year’s meeting featured scientific parallel sessions organised by the Belgian Society for Advancement of Cytometry (BSAC), the Belgian Society of Thrombosis and Haemostasis (BSTH), MolecularDiagnostics.be (MD.be) as well as a nurse symposium. In this article, we will highlight the scientific sessions presented during the BHS meeting.

(BELG J HEMATOL 2020;11(3):136–41)

New haematology reimbursements in Belgium

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2020;11(3):142–3)

Journal Scan

The goal of this new section in the BJH is to provide a snapshot of pivotal studies published in recent issues of the most important international journals focusing on haematology. Importantly, the selection of the studies discussed here is the sole responsibility of the publisher and was not influenced by third parties. Do you miss an important study, or did you read a hidden jewel that deserves to be shared with your colleagues? Please, let us know (editor@bjh.be) and we will make sure to include it in the journal scan section of the next BJH issue.

(BELG J HEMATOL 2020;11(2):79–81)

New haematology reimbursements in Belgium

OVERVIEW OF BELGIAN REIMBURSEMENT NEWS

(BELG J HEMATOL 2020;11(2):82)